PAX3 and SOX10 activate MET receptor expression in melanoma

Pigment Cell and Melanoma Research

Volumn 23, Issue 2, 2010, Pages 225-237

  Mascarenhas, Joseph B ^a   Littlejohn, Erica L ^a   Wolsky, Rebecca J ^a   Young, Kacey P ^a   Nelson, Maria ^a   Salgia, Ravi ^a   Lang, Deborah ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Melanoma; MET; MITF; PAX3; SOX10; Transcription

Indexed keywords

MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR SOX10;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; GENE ACTIVATION; GENE CONTROL; GROWTH INHIBITION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; NONHUMAN; PHENOTYPE; PRIMARY TUMOR; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL LINE, TUMOR; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; PAIRED BOX TRANSCRIPTION FACTORS; PROTO-ONCOGENE PROTEINS C-MET; RNA; RNA, SMALL INTERFERING; SOXE TRANSCRIPTION FACTORS;

EID: 77949371469     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2010.00667.x     Document Type: Article

References (41)

1. Beuret, L., Flori, E., Denoyelle, C., Bille, K., Busca, R., Picardo, M., Bertolotto, C., and Ballotti, R. (2007). Up-regulation of MET expression by alpha-melanocyte-stimulating hormone and MITF allows hepatocyte growth factor to protect melanocytes and melanoma cells from apoptosis. J. Biol. Chem. 282, 14140-14147.
2. Bondurand, N., Pingault, V., Goerich, D.E., Lemort, N., Sock, E., Caignec, C.L., Wegner, M., and Goossens, M. (2000). Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum. Mol. Genet. 9, 1907-1917.
3. Cook, A.L., Smith, A.G., Smit, D.J., Leonard, J.H., and Sturm, R.A. (2005). Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro. Exp. Cell Res., 308, 222-235.
4. Cruz, J., Reis-Filho, J.S., Silva, P., and Lopes, J.M. (2003). Expression of c-met tyrosine kinase receptor is biologically and prognostically relevant for primary cutaneous malignant melanomas. Oncology 65, 72-82.
5. Epstein, J.A., Shapiro, D.N., Cheng, J., Lam, P.Y., and Maas, R.L. (1996). Pax3 modulates expression of the c-Met receptor during limb muscle development. Proc. Natl. Acad. Sci. U S A 93, 4213-4218.
6. Gambarotta, G., Boccaccio, C., Giordano, S., Ando, M., Stella, M.C., and Comoglio, P.M. (1996). Ets up-regulates MET transcription. Oncogene 13, 1911-1917.
7. Garbe, C., and Leiter, U. (2009). Melanoma epidemiology and trends. Clin. Dermatol. 27, 3-9.
8. Gentile, A., Trusolino, L., and Comoglio, P.M. (2008). The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev. 27, 85-94.
9. Ginsberg, J.P., Davis, R.J., Bennicelli, J.L., Nauta, L.E., and Barr, F.G. (1998). Up-regulation of MET but not neural cell adhesion molecule expression by the PAX3-FKHR fusion protein in alveolar rhabdomyosarcoma. Cancer Res. 58, 3542-3546.
10. Gomes, D.A., Rodrigues, M.A., Leite, M.F., Gomez, M.V., Varnai, P., Balla, T., Bennett, A.M., and Nathanson, M.H. (2008). c-Met must translocate to the nucleus to initiate calcium signals. J. Biol. Chem. 283, 4344-4351.
11. Hodgkinson, C.A., Moore, K.J., Nakayama, A., Steingrimsson, E., Copeland, N.G., Jenkins, N.A., and Arnheiter, H. (1993). Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74, 395-404.
12. Jiao, Z., Mollaaghababa, R., Pavan, W.J., Antonellis, A., Green, E.D., and Hornyak, T.J. (2004). Direct interaction of Sox10 with the promoter of murine Dopachrome Tautomerase (Dct) and synergistic activation of Dct expression with Mitf. Pigment Cell Res. 17, 352-362.
13. King, R., Weilbaecher, K.N., McGill, G., Cooley, E., Mihm, M., and Fisher, D.E. (1999). Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis. Am. J. Pathol. 155, 731-738.
14. Kos, L., Aronzon, A., Takayama, H., Maina, F., Ponzetto, C., Merlino, G., and Pavan, W. (1999). Hepatocyte growth factor/scatter factor-MET signaling in neural crest-derived melanocyte development. Pigment Cell Res. 12, 13-21.
15. Kuhlbrodt, K., Herbarth, B., Sock, E., Hermans-Borgmeyer, I., and Wegner, M. (1998). Sox10, a novel transcriptional modulator in glial cells. J. Neurosci. 18, 237-250.
16. Kunisada, T., Yamazaki, H., Hirobe, T., Kamei, S., Omoteno, M., Tagaya, H., Hemmi, H., Koshimizu, U., Nakamura, T., and Hayashi, S.I. (2000). Keratinocyte expression of transgenic hepatocyte growth factor affects melanocyte development, leading to dermal melanocytosis. Mech. Dev. 94, 67-78.
17. Lang, D., and Epstein, J.A. (2003). Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. Hum. Mol. Genet. 12, 937-945.
18. Lang, D., Chen, F., Milewski, R., Li, J., Lu, M.M., and Epstein, J.A. (2000). Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-ret. J. Clin. Invest. 106, 963-971.
19. Lang, D., Lu, M.M., Huang, L., Engleka, K.A., Zhang, M., Chu, E.Y., Lipner, S., Skoultchi, A., Millar, S.E., and Epstein, J.A. (2005). Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 433, 884-887.
20. Liang, H., O'Reilly, S., Liu, Y., Abounader, R., Laterra, J., Maher, V.M., and McCormick, J.J. (2004). Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity. Int. J. Oncol. 24, 1057-1067.
21. Ludwig, A., Rehberg, S., and Wegner, M. (2004). Melanocyte-specific expression of dopachrome tautomerase is dependent on synergistic gene activation by the Sox10 and Mitf transcription factors. FEBS Lett. 556, 236-244.
22. Mascarenhas, J.B., Young, K.P., Littlejohn, E.L., Yoo, B.K., Salgia, R., and Lang, D. (2009). PAX6 is expressed in pancreatic cancer and actively participates in cancer progression through activation of the MET tyrosine kinase receptor gene. J. Biol. Chem. 284, 27524-27532.
23. McGill, G.G., Haq, R., Nishimura, E.K., and Fisher, D.E. (2006). c-Met expression is regulated by Mitf in the melanocyte lineage. J. Biol. Chem. 281, 10365-10373.
24. Natali, P.G., Nicotra, M.R., Di Renzo, M.F., Prat, M., Bigotti, A., Cavaliere, R., and Comoglio, P.M. (1993). Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression. Br. J. Cancer 68, 746-750.
25. Nonaka, D., Chiriboga, L., and Rubin, B.P. (2008). Sox10: a pan-schwannian and melanocytic marker. Am. J. Surg. Pathol. 32, 1291-1298.
26. Peirano, R.I., Goerich, D.E., Riethmacher, D., and Wegner, M. (2000). Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol. Cell. Biol. 20, 3198-3209.
27. Planque, N., Leconte, L., Coquelle, F.M., Martin, P., and Saule, S. (2001). Specific Pax-6/microphthalmia transcription factor interactions involve their DNA-binding domains and inhibit transcriptional properties of both proteins. J. Biol. Chem. 276, 29330-29337.
28. Plummer, R.S., Shea, C.R., Nelson, M., Powell, S.K., Freeman, D.M., Dan, C.P., and Lang, D. (2008). PAX3 expression in primary melanomas and nevi. Mod. Pathol. 21, 525-530.
29. Potterf, S.B., Furumura, M., Dunn, K.J., Arnheiter, H., and Pavan, W.J. (2000). Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum. Genet. 107, 1-6.
30. Pozner-Moulis, S., Pappas, D.J., and Rimm, D.L. (2006). Met, the hepatocyte growth factor receptor, localizes to the nucleus in cells at low density. Cancer Res. 66, 7976-7982.
31. Puri, N., Ahmed, S., Janamanchi, V., Tretiakova, M., Zumba, O., Krausz, T., Jagadeeswaran, R., and Salgia, R. (2007). c-Met is a potentially new therapeutic target for treatment of human melanoma. Clin. Cancer Res. 13, 2246-2253.
32. Saitoh, K., Takahashi, H., Sawada, N., and Parsons, P.G. (1994). Detection of the c-met proto-oncogene product in normal skin and tumours of melanocytic origin. J. Pathol. 174, 191-199.
33. Scholl, F.A., Kamarashev, J., Murmann, O.V., Geertsen, R., Dummer, R., and Schafer, B.W. (2001). PAX3 is expressed in human melanomas and contributes to tumor cell survival. Cancer Res. 61, 823-826.
34. Southard-Smith, E.M., Kos, L., and Pavan, W.J. (1998). Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat. Genet. 18, 60-64.
35. Takayama, H., LaRochelle, W.J., Sharp, R., Otsuka, T., Kriebel, P., Anver, M., Aaronson, S.A., and Merlino, G. (1997). Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc. Natl. Acad. Sci. U S A 94, 701-706.
36. Verastegui, C., Bille, K., Ortonne, J.P., and Ballotti, R. (2000). Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10. J. Biol. Chem. 275, 30757-30760.
37. Watanabe, A., Takeda, K., Ploplis, B., and Tachibana, M. (1998). Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. Nat. Genet. 18, 283-286.
38. Wei, Q., Miskimins, W.K., and Miskimins, R. (2004). Sox10 acts as a tissue-specific transcription factor enhancing activation of the myelin basic protein gene promoter by p27Kip1 and Sp1. J. Neurosci. Res. 78, 796-802.
39. Yang, G., Li, Y., Nishimura, E.K., Xin, H., Zhou, A., Guo, Y., Dong, L., Denning, M.F., Nickoloff, B.J., and Cui, R. (2008). Inhibition of PAX3 by TGF-beta modulates melanocyte viability. Mol. Cell 32, 554-563.
40. Zhang, X., Li, Y., Dai, C., Yang, J., Mundel, P., and Liu, Y. (2003). Sp1 and Sp3 transcription factors synergistically regulate HGF receptor gene expression in kidney. Am. J. Physiol. Renal Physiol. 284, F82-F94.
41. Zhu, L., Lee, H.O., Jordan, C.S., Cantrell, V.A., Southard-Smith, E.M., and Shin, M.K. (2004). Spatiotemporal regulation of endothelin receptor-B by SOX10 in neural crest-derived enteric neuron precursors. Nat. Genet. 36, 732-737.